• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Alcon launches Web site for patients with nasal allergies

Article

Alcon Laboratories Inc. announced in a prepared statement the launch of a new online resource for patients with nasal allergies: its new Web site for olopatadine (Patanase) nasal spray, www.patanese.com.

Fort Worth, TX

―Alcon Laboratories Inc. announced in a prepared statement the launch of a new online resource for patients with nasal allergies: its new Web site for olopatadine (Patanase) nasal spray,

www.patanase.com

.

The site features facts about the causes of seasonal allergies, an interactive symptoms poll, complete product prescribing information and instructions, and a mail-in rebate for patients.

“This Web site is a great resource since more patients are doing online research to learn about their allergies,” said Bobby Lanier, MD, clinical professor at the University of North Texas Health Science Center, Fort Worth. “It addresses the important need for patients to understand their symptoms and how to get quick, safe relief.”

Olopatadine is a steroid-free nasal spray indicated for the relief of the symptoms of seasonal allergic rhinitis in patients aged 12 or more years.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.